UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Acute Myeloid Leukemia · Pediatric AML

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Texas Children's Cancer and Hematology Center, Houston, Texas, United States
Contact: Study coordinator (Joanna S Yi, MD) · jsyi@texaschildrens.org · 832-824-6699
Contact: Study coordinator (Alexandra M Stevens, MD, PhD) · amsteven@texaschildrens.org · 832-824-4824

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

High Risk Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)

Abroad (travel likely)RecruitingPHASE1

Nanchang, China · Nanchang, China